Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?

One fund is quietly buying into ACADIA — just as the company posts one of its strongest quarters in years.Connecticut-based fund Braidwell established a new position in ACADIA Pharmaceuticals (ACAD +1.77%), adding nearly 2.4 million shares, a stake valued at about $50.8 million as of September 30.What HappenedAccording to a filing with the U.S. Securities and Exchange Commission dated November 14, Braidwell disclosed a new stake in ACADIA Pharmaceuticals, acquiring nearly 2.4 million shares valued at approx ...